Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind, placebo-controlled dose-escalation study evaluated intravenous PDA001 human placenta-derived cells for Crohn's disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PDA001

Snippet

Sponsor: Celularity Incorporated | Conditions: Crohns Disease | Phase 1 | Status: COMPLETED